PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in orthopedic 2D/3D imaging, hosted a radiology administrator EOS® users’ group meeting held in conjunction with the Association for Medical Imaging Management (AHRA) Annual Meeting, Aug. 10-13, 2014 in Washington, D.C.
AHRA is a premier educational event for radiology administrators. The AHRA 2014 annual meeting hosted nearly 1,000 imaging leaders and 200 exhibitors. EOS imaging held a half-day users’ meeting in concert with AHRA on August 12, 2014. The EOS event was followed by more than 50 radiology professionals from EOS sites across the U.S. and Canada, including Rady Children’s Hospital in San Diego, The Children’s Hospital of Philadelphia, The Hospital for Sick Children in Toronto and several Shriners Hospitals for Children across North America. Some of the EOS users joined remotely, streaming the EOS sessions via the internet.
The meeting highlighted the utilization of EOS imaging to reduce radiation exposure in pediatric patients. The EOS system provides full-body images of patients in a natural standing or seated position in both 2D and 3D with 50% to 85% less radiation dose than standard radiology and 95% less dose than basic CT scans, in accordance with the ALARA (As Low As Reasonably Achievable) principle of radiation reduction.
“The EOS equipment is a key element in our strategy to reduce the radiation dose delivered to our pediatric patients," said Chris Tomlinson, M.B.A., C.R.A., Sr. Director, Radiology and Executive Director, Radiology Associates of The Children's Hospital of Philadelphia. "The participating EOS users, myself included, appreciated a venue to share our EOS imaging successes and to learn from each other with the goal of developing best practices to help our hospitals continue to lower radiation dose to our patients.”
Other topics covered included general sessions about EOS as a new orthopedic imaging modality, routine use of the EOS system, maximizing EOS image quality, optimizing patient positioning for EOS images and expanding uses for the images. EOS users also presented on topics as varied as how to conduct specialty exams in an EOS system; how to manage patient workflows; and how to communicate about the EOS system to new patients.
Marie Meynadier, CEO of EOS imaging, said, “Our customers benefited from the sharing of best practices related to the functional and business aspects of the EOS system. Additionally, the topic of reducing radiation exposure continued to be a major theme for these radiology professionals. EOS is proud to have been and keep being a pioneer in this area, helping lead the way to safer radiographic imaging.”
For more information, please visit www.eos-imaging.com.
About EOS imaging:
EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 32 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of more than 80 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2013 the Group posted 2013 consolidated revenue of €15.2 million and employed 101 people including an R&D team of 38 engineers. The Group is based in Paris and holds four subsidiaries in Besançon (France), Cambridge (Massachusetts), in Montreal (Canada) and Frankfurt (Germany), and offices in Singapore. For further information, please visit www.eos-imaging.com
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
Next press release: 2014 first half results, on Sept. 1, 2014 (after market).